[HTML][HTML] Metformin and cancer hallmarks: molecular mechanisms in thyroid, prostate and head and neck cancer models
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …
described by clinical studies showing reduced risk of cancer development in T2DM patients …
Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models.
MG Morale, RE Tamura, IGS Rubio - Biomolecules, 2022 - europepmc.org
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …
described by clinical studies showing reduced risk of cancer development in T2DM patients …
Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
MG Morale, RE Tamura, IGS Rubio - 2022 - agris.fao.org
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …
described by clinical studies showing reduced risk of cancer development in T2DM patients …
Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models.
MG Morale, RE Tamura… - Biomolecules (2218 …, 2022 - search.ebscohost.com
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …
described by clinical studies showing reduced risk of cancer development in T2DM patients …
[HTML][HTML] Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
MG Morale, RE Tamura, IGS Rubio - Biomolecules, 2022 - ncbi.nlm.nih.gov
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …
described by clinical studies showing reduced risk of cancer development in T2DM patients …
[PDF][PDF] Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
MG Morale, RE Tamura, IGS Rubio - Cancer Cells, 2014 - pdfs.semanticscholar.org
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …
described by clinical studies showing reduced risk of cancer development in T2DM patients …
[引用][C] 1. Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
MG Morale - spandidos-publications.com
Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
MG Morale, RE Tamura, IGS Rubio - Biomolecules, 2022 - pubmed.ncbi.nlm.nih.gov
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …
described by clinical studies showing reduced risk of cancer development in T2DM patients …
[PDF][PDF] Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
MG Morale, RE Tamura, IGS Rubio - Cancer Cells, 2014 - academia.edu
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …
described by clinical studies showing reduced risk of cancer development in T2DM patients …
Metformin and Cancer Hallmarks: Molecular Mechanisms in Thyroid, Prostate and Head and Neck Cancer Models
MG Morale, RE Tamura, IGS Rubio - Biomolecules, 2022 - search.proquest.com
Metformin is the most used drug for type 2 diabetes (T2DM). Its antitumor activity has been
described by clinical studies showing reduced risk of cancer development in T2DM patients …
described by clinical studies showing reduced risk of cancer development in T2DM patients …